Earnings NewsPMV Pharmaceuticals GAAP EPS of -$1.28 misses by $0.05Mar. 01, 2022 7:51 AM ETPMV Pharmaceuticals, Inc. (PMVP)By: Deepa Sarvaiya, SA News Editor PMV Pharmaceuticals press release (NASDAQ:PMVP): FY GAAP EPS of -$1.28 misses by $0.05. Cash, cash equivalents, and marketable securities as of December 31, 2021 of $314.4M compared to $361.4 million as of December 31, 2020. Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.